Paper5337399
Studies on bleomycin.
Umezawa H and 3 others. Cancer, 1967. Cited by 191 papers, by iCite.
Cite this record
ConductScience Library. Studies on bleomycin. Papers, record 5337399. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5337399
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Carcinoma, Ehrlich Tumor | Major topic |
| Culture Techniques | Major topic |
| Escherichia coli | Major topic |
| Animals | |
| DNA, Bacterial | |
| Dogs | |
| HeLa Cells | |
| Mice | |
| Rabbits | |
| Sarcoma 180 |
Source PubMed
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42613079 | Murine models of pulmonary fibrosis: mechanisms, limitations and translational insights. | Eur Respir Rev | 2026 | https://conductscience.org/library/papers/42613079 | PubMed |
| 41599636 | FAPI Tracer en Vogue: Evaluating [68Ga]Ga-DATA5m.SA.FAPi for Molecular Imaging of Pulmonary Fibrosis. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41599636 | PubMed |
| 37725153 | Baicalin and lung diseases. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/37725153 | PubMed |
| 36834561 | Immune Mechanisms of Pulmonary Fibrosis with Bleomycin. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834561 | PubMed |
| 36176753 | Electrochemotherapy using thin-needle electrode improves recovery in feline nasal planum squamous cell carcinoma - a translational model. | Cancer Drug Resist | 2022 | https://conductscience.org/library/papers/36176753 | PubMed |
| 36139200 | Retrospective Evaluation of a Combination of Carboplatin and Bleomycin for the Treatment of Canine Carcinomas. | Animals (Basel) | 2022 | https://conductscience.org/library/papers/36139200 | PubMed |
| 34943779 | Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints. | Cells | 2021 | https://conductscience.org/library/papers/34943779 | PubMed |
| 34683897 | Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34683897 | PubMed |
| 34028755 | Mouse Models of Skin Fibrosis. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/34028755 | PubMed |
| 31935268 | Optimization of cytotoxic activity of Nocardia sp culture broths using a design of experiments. | PLoS One | 2020 | https://conductscience.org/library/papers/31935268 | PubMed |
| 30594446 | Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma. | Clin Lymphoma Myeloma Leuk | 2019 | https://conductscience.org/library/papers/30594446 | PubMed |
| 29740320 | Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29740320 | PubMed |
| 29172151 | Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia. | Redox Biol | 2018 | https://conductscience.org/library/papers/29172151 | PubMed |
| 28769196 | PULMONARY LESIONS ASSOCIATED WITH BLEOMYCIN THERAPY IN MALIGNANCIES. | Med J Armed Forces India | 1994 | https://conductscience.org/library/papers/28769196 | PubMed |
| 28677860 | Molecular Magnetic Resonance Imaging of Lung Fibrogenesis with an Oxyamine-Based Probe. | Angew Chem Int Ed Engl | 2017 | https://conductscience.org/library/papers/28677860 | PubMed |
| 24985397 | IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. | J Allergy Clin Immunol | 2014 | https://conductscience.org/library/papers/24985397 | PubMed |
| 24583879 | Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. | Am J Physiol Lung Cell Mol Physiol | 2014 | https://conductscience.org/library/papers/24583879 | PubMed |
| 19129758 | Pulmonary fibrosis: pathogenesis, etiology and regulation. | Mucosal Immunol | 2009 | https://conductscience.org/library/papers/19129758 | PubMed |
| 17936056 | The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? | Int J Biochem Cell Biol | 2008 | https://conductscience.org/library/papers/17936056 | PubMed |
| 16752933 | Dose adaptation of antineoplastic drugs in patients with liver disease. | Drug Saf | 2006 | https://conductscience.org/library/papers/16752933 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5337399
GET https://conductscience.org/api/papers/v1/5337399/cited_by?page=2